In the United States, mitochondrial transfer is being treated as a regulatory matter by the Food and Drug Administration . Although this approach might make the procedure available to parents more quickly than would a broader public dialogue, the stakes are too high for this to be a regulatory matter alone. The United States should follow Britain’s lead and begin a national conversation about mitochondrial transfer and the future of human genetic manipulation.
It’s Time for the United States to Talk About Genetics
